Procter & Gamble stock holds firm as fiscal 2025 sales reached $84.3 billion

Procter & Gamble stock stays anchored by fiscal 2025 sales of $84.3 billion (US7427181091), with net earnings of $16.0 billion and fourth-quarter organic sales up 2% year over year, a mix that keeps the consumer staples giant in the market conversation even without a fresh company release in this call.

Fiscal 2025 sales at $84.3 billion

In fiscal 2025, Procter & Gamble reported net sales of $84.3 billion and net earnings of $16.0 billion, according to its annual results on the company investor site. The same results showed core earnings per share of $6.83 for the year, giving investors a clear baseline for the stock’s valuation backdrop.

The company also said fourth-quarter organic sales rose 2% from a year earlier, which is the most useful comparison in the latest report because it ties the annual base to current trading momentum. That combination of $84.3 billion in sales, $16.0 billion in earnings, and 2% organic growth is the central read-through for the shares.

Margin and cash remain central

For fiscal 2025, Procter & Gamble said operating cash flow reached $18.8 billion, while adjusted free cash flow productivity came in at 90%. Those figures matter because they show how much of the earnings base turned into cash during the year.

The company also reported a quarterly dividend of $1.0568 per share in its latest declared payout, a reminder that the stock continues to trade partly as an income name. On a relative basis, the 2% fourth-quarter organic sales increase is modest, but it still supports the idea that the portfolio remains resilient across categories and regions.

Consumer staples with scale

Procter & Gamble’s portfolio spans household and personal-care brands, and the fiscal 2025 numbers show why that scale matters. The year’s $84.3 billion revenue base and $18.8 billion of operating cash flow are the two figures that best capture the business strength behind the stock.

That scale also explains why the shares often move less on product headlines than on margin, cash conversion, and growth consistency. For investors, the annual numbers are doing most of the work here.

Stock level and venue

Procter & Gamble stock trades on the New York Stock Exchange in USD, and the company closed fiscal 2025 with a market backdrop defined by $84.3 billion in sales and $6.83 in core EPS. The latest full-year results provide the cleanest dated reference point for the share story in this call.